0.0002
-0.0298
(-99.33%)
As of April 11 at 4:00:00 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Kenneth Clifford Phillippe B.Comm, CA, CPA | Chief Financial Officer | 17.77k | -- | 1952 |
| Mr. Martin John Courtney Woodward | Secretary & Independent Director | -- | -- | 1968 |
| Dr. Benjamin Krantz M.B.A., M.D. | President, CEO & Director | -- | -- | -- |
Advanced Proteome Therapeutics Corporation
8337 Eastlake Drive
Suite 104
Burnaby, BC V5A 4W2
Canada
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.
Corporate Governance
Advanced Proteome Therapeutics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
May 8, 2019 at 12:00 AM UTC
Dividend Date